KRAS and pachyonychia congenita: Moreover, KRAS mutations can lead to persistent activation of RalA/B through the RalGEF/Ral signaling pathway, regulating endocytosis and exocytosis and affecting the distribution of cell-surface receptors and growth factors, ultimately promoting the proliferation, migration, and metastasis of PC cells [279].